Gout Therapeutics Market Strategies and Forecasts, 2020 to 2026

1. Gout Therapeutics Market Market Size Worth $6,304.8 Million By 2026 | CAGR:14.8%

2. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 “According to Polaris Market Research report, Gout Therapeutics market is witnessing a major transformation and is projected to reach $6,304.8 Million By 2026 registering a CAGR of 14.8% during the forecast period 2020 to 2026.” The global Gout Therapeutics market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Gout Therapeutics market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals. Gout Therapeutics Market Report Scope: The study provides a comprehensive view of the Gout Therapeutics market by segmenting it based on Drug Class, Disease Condition and region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Gout Therapeutics market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Gout Therapeutics Market Analysis: https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics-market - 2 -

3. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 By Drug Class By Disease Condition By Region •Non-steroidal Anti- Inflammatory Drugs (NSAIDs) •Corticosteroids •Colchicine •Urate Lowering Agents •Acute •Chronic •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Impact Analysis of COVID-19 on Gout Therapeutics Market The global Gout Therapeutics market is anticipated to continue its growth amid the covid-19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Gout Therapeutics market, owing to the presence of several leading local and international players operating in the regional market. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Gout Therapeutics market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry- analysis/gout-therapeutics-market/speak-to-analyst - 3 -

4. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 Competitive Landscape Leading companies holding significant market shares in the Gout Therapeutics market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Gout Therapeutics market include AstraZeneca, Horizon Pharma Plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc, Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics- market/request-for-sample Table of Contents 1.Chapter 1. Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Chapter 2. Executive Summary 2.1.Market Highlights 3.Chapter 3. Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Chapter 4. Market Analysis 4.1.Overview 4.2.Gout Therapeutics Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Growing Geriatric Population 4.2.1.2. Increasing incidence and prevalence of gout 4.2.1.3. Growing research and development activities 4.2.2.Restraints and Challenges 4.2.2.1. High cost of new and improved drugs 4.2.2.2. Patent expiry of various blockbuster drugs 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats Of New Entrants: (High) - 4 -

5. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 4.3.3.Bargaining Power Of Buyers (High) 4.3.4.Threats Of Substitute (Moderate) 4.3.5.Rivalry Among The Existing Competitors (Moderate) 4.4.PESTLE Analysis 4.5.Gout Therapeutics Market Industry trends 4.5.1.Newer treatments for gout 4.6.Competitive Ranking Analysis 5.Chapter 5. Gout Therapeutics Market Assessment by Drug Class 5.1.KEY FINDINGS 5.2.Introduction 5.2.1.Global Gout Therapeutics Market, By Type, 2015 – 2026 (USD Million) 5.3.Non-steroidal Anti-Inflammatory Drugs (NSAIDs) 5.3.1.Global Gout Therapeutics NSAIDs Market, by Region, 2015-2026 (USD Million) 5.3.2.North America: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.3.Europe: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.4.Asia-Pacific: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.5.LATAM: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.3.6.MEA: Gout Therapeutics NSAIDs Market, by Country, 2015-2026 (USD Million) 5.4.Corticosteroids 5.4.1.Global Gout Therapeutics Corticosteroids Market, by Region, 2015-2026 (USD Million) 5.4.2.North America: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.3.Europe: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.4.Asia-Pacific: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.5.LATAM: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.4.6.MEA: Gout Therapeutics Corticosteroids Market, by Country, 2015-2026 (USD Million) 5.5.Colchicine 5.5.1.Global Gout Therapeutics Colchicine Market, by Region, 2015-2026 (USD Million) 5.5.2.North America: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.3.Europe: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.4.Asia-Pacific: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.5.LATAM: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.5.6.MEA: Gout Therapeutics Colchicine Market, by Country, 2015-2026 (USD Million) 5.6.Urate Lowering Agents 5.6.1.Global Gout Therapeutics Urate Lowering Agents Market, by Region, 2015-2026 (USD Million) 5.6.2.North America: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) - 5 -

6. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 5.6.3.Europe: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) 5.6.4.Asia-Pacific: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015- 2026 (USD Million) 5.6.5.LATAM: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015- 2026 (USD Million) 5.6.6.MEA: Gout Therapeutics Urate Lowering Agents Market, by Country, 2015-2026 (USD Million) 6.Chapter 6. Gout Therapeutics Market Assessment by Disease Condition 6.1.KEY FINDINGS 6.2.Introduction 6.2.1.Global Gout Therapeutics Market, By Disease Condition, 2015 – 2026 (USD Million) 6.3.Acute Gout 6.3.1.Global Acute Gout Therapeutics Market, by Region, 2015-2026 (USD Million) 6.3.2.North America: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.3.3.Europe: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.3.4.Asia-Pacific: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.3.5.LATAM: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.3.6.MEA: Acute Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.Chronic 6.4.1.Global Chronic Gout Therapeutics Market, by Region, 2015-2026 (USD Million) 6.4.2.North America: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.3.Europe: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.4.Asia-Pacific: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.5.LATAM: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 6.4.6.MEA: Chronic Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.Chapter 7. Gout Therapeutics Market Assessment by Geography 7.1.KEY FINDINGS 7.2.Introduction 7.2.1.Gout Therapeutics Market Assessment, By Geography, 2015-2026 (USD Million) 7.3.NORTH AMERICA 7.3.1.North America: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.3.2.North America: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.3.3.North America: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.3.4.U.S. 7.3.4.1. U.S.: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.3.4.2. U.S.: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.3.5.Canada 7.3.5.1. Canada: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.3.5.2. Canada: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) - 6 -

7. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 7.4.EUROPE 7.4.1.Europe: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.4.2.Europe: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.3.Europe: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.4.Germany 7.4.4.1. Germany: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.4.2. Germany: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.5.UK 7.4.5.1. UK: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.5.2. UK: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.6.France 7.4.6.1. France: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.6.2. France: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.7.Italy 7.4.7.1. Italy: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.7.2. Italy: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.8.Spain 7.4.8.1. Spain: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.8.2. Spain: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.9.Belgium 7.4.9.1. Belgium: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.9.2. Belgium: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.4.10.Rest of Europe 7.4.10.1.Rest of Europe: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.4.10.2.Rest of Europe: Gout Therapeutics Market, By Disease Condition, 2015- 2026 (USD Million) 7.5.ASIA-PACIFIC 7.5.1.Asia Pacific: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.5.2.Asia Pacific: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.3.Asia Pacific: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.4.China 7.5.4.1. China: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.4.2. China: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.5.India 7.5.5.1. India: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.5.2. India: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.6.Japan - 7 -

8. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 7.5.6.1. 7.5.6.2. Japan: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) Japan: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.7.South Korea 7.5.7.1. South Korea: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.7.2. South Korea: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.8.Australia 7.5.8.1. Australia: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.8.2. Australia: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.5.9.Rest of APAC 7.5.9.1. Rest of APAC: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.5.9.2. Rest of APAC: Gout Therapeutics Market, By Disease Condition, 2015- 2026 (USD Million) 7.6.LATIN AMERICA 7.6.1.Latin America: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.6.2.Latin America: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.3.Latin America: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.6.4.Brazil 7.6.4.1. Brazil: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.4.2. Brazil: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.6.5.Mexico 7.6.5.1. Mexico: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.5.2. Mexico: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.6.6.Rest of LATAM 7.6.6.1. Rest of LATAM: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.6.6.2. Rest of LATAM: Gout Therapeutics Market, By Disease Condition, 2015- 2026 (USD Million) 7.7.MIDDLE EAST AND AFRICA 7.7.1.Middle East & Africa: Gout Therapeutics Market, by Country, 2015-2026 (USD Million) 7.7.2.Middle East & Africa: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.7.3.Middle East & Africa: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.7.4.South Africa 7.7.4.1. South Africa: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.7.4.2. South Africa: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.7.5.Saudi Arabia - 8 -

9. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 7.7.5.1. Saudi Arabia: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.7.5.2. Saudi Arabia: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 7.7.6.Rest of Middle East and Africa 7.7.6.1. Rest of MEA: Gout Therapeutics Market, By Drug Class, 2015-2026 (USD Million) 7.7.6.2. Rest of MEA: Gout Therapeutics Market, By Disease Condition, 2015-2026 (USD Million) 8.Chapter 8. Competitive Landscape 8.1.Agreements, Collaborations, Product Developments and launch Analysis 8.1.1.Strategic Analysis – Gout Therapeutics Market 8.2.Prouct/Service Launch 8.3.Partnerships/Collaborations/Agreements 8.4.Approvals 8.5.Others 9.Chapter 9. Company Profiles 9.1.AstraZeneca 9.1.1.Business Overview 9.1.2.Financial Snapshot 9.1.3.Products and Services 9.1.4.Recent Developments 9.2.Horizon Pharma Plc 9.2.1.Business Overview 9.2.2.Financial Snapshot 9.2.3.Products and Services 9.2.4.Recent Developments 9.3.Takeda Pharmaceutical Company Limited 9.3.1.Business Overview 9.3.2.Financial Snapshot 9.3.3.Products and Services 9.3.4.Recent Developments 9.4.GlaxoSmithKline plc 9.4.1.Business Overview 9.4.2.Financial Snapshot 9.4.3.Products and Services 9.4.4.Recent Developments 9.5.Novartis AG 9.5.1.Business Overview 9.5.2.Financial Snapshot 9.5.3.Products and Services 9.5.4.Recent Developments 9.6.Merck & Co. Inc. 9.6.1.Business Overview 9.6.2.Financial Snapshot 9.6.3.Products and Services 9.6.4.Recent Developments 9.7.Teijin Pharma Limited 9.7.1.Business Overview 9.7.2.Financial Snapshot - 9 -

10. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 9.7.3.Products and Services 9.7.4.Recent Developments 9.8.Regeneron Pharmaceuticals, Inc. 9.8.1.Business Overview 9.8.2.Financial Snapshot 9.8.3.Products and Services 9.8.4.Recent Developments 9.9.Ironwood Pharmaceuticals, Inc. 9.9.1.Business Overview 9.9.2.Financial Snapshot 9.9.3.Products and Services 9.9.4.Recent Developments 9.10. JW Pharmaceutical 9.10.1.Business Overview 9.10.2.Financial Snapshot 9.10.3.Products and Services 9.10.4.Recent Developments 9.11. Selecta Biosciences, Inc. 9.11.1.Business Overview 9.11.2.Financial Snapshot 9.11.3.Products and Services 9.11.4.Recent Developments 9.12. Grunenthal Group 9.12.1.Business Overview 9.12.2.Financial Snapshot 9.12.3.Products and Services 9.12.4.Recent Developments Access Press Release on Gout Therapeutics Market: https://www.polarismarketresearch.com/press- releases/global-gout-therapeutics-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com - 10 -

11. Gout Therapeutics Market Size Worth $6,304.8 Million By 2026 Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 11 -